A preliminary analysis of the TIME and PD-1/PD-L1 therapeutic reactivity in the BLCA patients indicated that OBSCN expression deficiency may induce the BLCA to recruit more CD8+T cells. The gene discussed is CD274; the disease is bladder transitional cell carcinoma.